EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?

Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?

Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds

EP 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing

Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change

Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy

EP 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, & Engagement

EP 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026

ACNU Explained: How FDA’s New Nonprescription Pathway Could Expand Access and Improve Adherence

Year in Review: The Healthcare Shifts That Defined 2025 and What’s Ahead in 2026

Exploring AI Patient Care and Clinical Decision Making with Carole Tremonti

The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next

ACNU Live Panels Follow-Up: Deep Dive Virtual Panel On FDA’s New ACNU Rule

The Future of the Journal of Clinical Pathways with Winston Wong

Insights from Health Rosetta Fest 2025

OHP Live from the Nicholas Hall Discussion 2| Episode 27: Nonprescription Access to Drug Treatment

OHPLive! Nicholas Hall Panel Discussion 1 Non prescription access to drug treatment

Breaking Down the $80 Billion 340B Drug Program with William Sarraille | Only Healthcare Podcast #25

How Cell and Gene Therapies Can Bankrupt Unprepared Employers | Only Healthcare Podcast #24

Healthcare’s Lightning Strike Cost Problem with Drew Wilkins | Only Healthcare Podcast #23

The Healthcare Insurance Industry's Hidden Agenda with Tamara Thomas | Only Healthcare Podcast #22

Breaking the Healthcare Monopoly with Dave Chase and Steve Ditto | Only Healthcare Podcast #21

GLP-1s: The Billion Dollar Dilemma in US Healthcare | Only Healthcare Podcast #20

Why Are Prescription Drugs So Expensive? | Episode #19

Why the US Spends the Most on Healthcare But Gets the Worst Outcomes | Only Healthcare Podcast #18

Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?

Confronting the Affordability Crisis: Unmasking the True Cost of Healthcare

Policy and Power: Dismantling Middleman Dominance in Healthcare

Clear Costs, Clearer Choices: Unpacking Trump’s Transparency Drive in Healthcare

Policy and Power: Dismantling Middleman Dominance in Healthcare

Rethinking Risk: Innovating Benefit Design for Whole-Person Care

Navigating the Future of Healthcare Policy

Transforming Healthcare: Innovations in Clinical Pathways with Dr. Randy Vogenberg

What Can Be Done to Bridge the Gap Between Employer-Manufacturer Collaboration

Unlocking Access and Collaboration: The Benefits of Employer-Pharma Relationships

How Employer-Pharmaceutical Collaboration Can Transform Healthcare Plans

Bridging the Gap: How Employer-Pharmaceutical Collaboration Can Transform Healthcare Plans

Navigating State-Level Legislation & The Future of Patient-Centered Care

Ask The Expert with Michael Navin: Unpacking the Latest Prescription Lawsuits

GLP-1 Drugs: Rapid Growth and Market Evolution

Ask the Expert: How Government Policies Influence Commercial Insurance Implications

Ask the Expert with Dr. Randy Vogenberg: How Government Policies Influence Commercial Insurance I...

Episode 2: How Employer Decisions Impact Coverage & Reimbursement

ONLY HEALTHCARE PODCAST, EPISODE 1: Exploring Healthcare Stakeholder Interactions

How Employer Decisions Impact Coverage & Reimbursement